TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹7,364 Cr | ₹6,796 Cr | ₹6,077 Cr | ₹5,524 Cr | ₹5,769 Cr |
What is the latest Total Expenditure of TORRENT PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹7,364 Cr |
| Mar2024 | ₹6,796 Cr |
| Mar2023 | ₹6,077 Cr |
| Mar2022 | ₹5,524 Cr |
| Mar2021 | ₹5,769 Cr |
How is Total Expenditure of TORRENT PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,364 Cr | 8.36 | |
| Mar2024 | ₹6,796 Cr | 11.84 | |
| Mar2023 | ₹6,077 Cr | 10.00 | |
| Mar2022 | ₹5,524 Cr | -4.24 | |
| Mar2021 | ₹5,769 Cr | - | |
Compare Total Expenditure of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹141,727.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,209.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,750.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,851.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,268.4 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
| MANKIND PHARMA | ₹88,493.9 Cr | 3.1% | 2.5% | -9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.2% |
-1.8% |
33.6% |
| SENSEX | 1.3% |
5.3% |
6.3% |
You may also like the below Video Courses